158 related articles for article (PubMed ID: 23339543)
1. Comparison of nanocomplexes with branched and linear peptides for siRNA delivery.
Tagalakis AD; Saraiva L; McCarthy D; Gustafsson KT; Hart SL
Biomacromolecules; 2013 Mar; 14(3):761-70. PubMed ID: 23339543
[TBL] [Abstract][Full Text] [Related]
2. Receptor-targeted liposome-peptide nanocomplexes for siRNA delivery.
Tagalakis AD; He L; Saraiva L; Gustafsson KT; Hart SL
Biomaterials; 2011 Sep; 32(26):6302-15. PubMed ID: 21624650
[TBL] [Abstract][Full Text] [Related]
3. Early-stage development of novel cyclodextrin-siRNA nanocomplexes allows for successful postnebulization transfection of bronchial epithelial cells.
Hibbitts A; O'Mahony AM; Forde E; Nolan L; Ogier J; Desgranges S; Darcy R; MacLoughlin R; O'Driscoll CM; Cryan SA
J Aerosol Med Pulm Drug Deliv; 2014 Dec; 27(6):466-77. PubMed ID: 24665866
[TBL] [Abstract][Full Text] [Related]
4. Enhanced siRNA delivery using cationic liposomes with new polyarginine-conjugated PEG-lipid.
Kim HK; Davaa E; Myung CS; Park JS
Int J Pharm; 2010 Jun; 392(1-2):141-7. PubMed ID: 20347025
[TBL] [Abstract][Full Text] [Related]
5. Delivery of siRNA using ternary complexes containing branched cationic peptides: the role of peptide sequence, branching and targeting.
Kudsiova L; Welser K; Campbell F; Mohammadi A; Dawson N; Cui L; Hailes HC; Lawrence MJ; Tabor AB
Mol Biosyst; 2016 Mar; 12(3):934-51. PubMed ID: 26794416
[TBL] [Abstract][Full Text] [Related]
6. Systematic Comparisons of Formulations of Linear Oligolysine Peptides with siRNA and Plasmid DNA.
Kwok A; McCarthy D; Hart SL; Tagalakis AD
Chem Biol Drug Des; 2016 May; 87(5):747-63. PubMed ID: 26684657
[TBL] [Abstract][Full Text] [Related]
7. Characterization of long-circulating cationic nanoparticle formulations consisting of a two-stage PEGylation step for the delivery of siRNA in a breast cancer tumor model.
Ho EA; Osooly M; Strutt D; Masin D; Yang Y; Yan H; Bally M
J Pharm Sci; 2013 Jan; 102(1):227-36. PubMed ID: 23132529
[TBL] [Abstract][Full Text] [Related]
8. The gene-silencing effect of siRNA in cationic lipoplexes is enhanced by incorporating pDNA in the complex.
Tagami T; Barichello JM; Kikuchi H; Ishida T; Kiwada H
Int J Pharm; 2007 Mar; 333(1-2):62-9. PubMed ID: 17097247
[TBL] [Abstract][Full Text] [Related]
9. Delivery of ENaC siRNA to epithelial cells mediated by a targeted nanocomplex: a therapeutic strategy for cystic fibrosis.
Manunta MDI; Tagalakis AD; Attwood M; Aldossary AM; Barnes JL; Munye MM; Weng A; McAnulty RJ; Hart SL
Sci Rep; 2017 Apr; 7(1):700. PubMed ID: 28386087
[TBL] [Abstract][Full Text] [Related]
10. Strategies for improving the safety and RNAi efficacy of noncovalent peptide/siRNA nanocomplexes.
Wang J; Chen G; Liu N; Han X; Zhao F; Zhang L; Chen P
Adv Colloid Interface Sci; 2022 Apr; 302():102638. PubMed ID: 35299136
[TBL] [Abstract][Full Text] [Related]
11. Multifunctional, self-assembling anionic peptide-lipid nanocomplexes for targeted siRNA delivery.
Tagalakis AD; Lee DH; Bienemann AS; Zhou H; Munye MM; Saraiva L; McCarthy D; Du Z; Vink CA; Maeshima R; White EA; Gustafsson K; Hart SL
Biomaterials; 2014 Sep; 35(29):8406-15. PubMed ID: 24985735
[TBL] [Abstract][Full Text] [Related]
12. FRET-labeled siRNA probes for tracking assembly and disassembly of siRNA nanocomplexes.
Alabi CA; Love KT; Sahay G; Stutzman T; Young WT; Langer R; Anderson DG
ACS Nano; 2012 Jul; 6(7):6133-41. PubMed ID: 22693946
[TBL] [Abstract][Full Text] [Related]
13. Phosphorylatable short peptide conjugated low molecular weight chitosan for efficient siRNA delivery and target gene silencing.
Kong F; Liu G; Sun B; Zhou S; Zuo A; Zhao R; Liang D
Int J Pharm; 2012 Jan; 422(1-2):445-53. PubMed ID: 22067703
[TBL] [Abstract][Full Text] [Related]
14. Multifunctional receptor-targeted nanocomplexes for magnetic resonance imaging and transfection of tumours.
Kenny GD; Villegas-Llerena C; Tagalakis AD; Campbell F; Welser K; Botta M; Tabor AB; Hailes HC; Lythgoe MF; Hart SL
Biomaterials; 2012 Oct; 33(29):7241-50. PubMed ID: 22809644
[TBL] [Abstract][Full Text] [Related]
15. Redox-responsive, reversibly-crosslinked thiolated cationic helical polypeptides for efficient siRNA encapsulation and delivery.
Zheng N; Song Z; Liu Y; Zhang R; Zhang R; Yao C; Uckun FM; Yin L; Cheng J
J Control Release; 2015 May; 205():231-9. PubMed ID: 25683619
[TBL] [Abstract][Full Text] [Related]
16. Chitosan-based hybrid nanocomplex for siRNA delivery and its application for cancer therapy.
Ki MH; Kim JE; Lee YN; Noh SM; An SW; Cho HJ; Kim DD
Pharm Res; 2014 Dec; 31(12):3323-34. PubMed ID: 24858398
[TBL] [Abstract][Full Text] [Related]
17. Peptide and nucleic acid-directed self-assembly of cationic nanovehicles through giant unilamellar vesicle modification: Targetable nanocomplexes for in vivo nucleic acid delivery.
Tagalakis AD; Maeshima R; Yu-Wai-Man C; Meng J; Syed F; Wu LP; Aldossary AM; McCarthy D; Moghimi SM; Hart SL
Acta Biomater; 2017 Mar; 51():351-362. PubMed ID: 28110069
[TBL] [Abstract][Full Text] [Related]
18. [Research on cationic vector-mediated RNAi].
Zhang X; Ding H; Wang B; Cui S; Zhao Y; Jin W; Zhang S; Jin M
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2012 Aug; 29(4):722-6. PubMed ID: 23016424
[TBL] [Abstract][Full Text] [Related]
19. siRNA delivery to lung-metastasized tumor by systemic injection with cationic liposomes.
Hattori Y; Nakamura A; Arai S; Kawano K; Maitani Y; Yonemochi E
J Liposome Res; 2015; 25(4):279-86. PubMed ID: 25543847
[TBL] [Abstract][Full Text] [Related]
20. Inhalable dry powder formulations of siRNA and pH-responsive peptides with antiviral activity against H1N1 influenza virus.
Liang W; Chow MY; Lau PN; Zhou QT; Kwok PC; Leung GP; Mason AJ; Chan HK; Poon LL; Lam JK
Mol Pharm; 2015 Mar; 12(3):910-21. PubMed ID: 25599953
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
